Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I; Specchio-COVID19 Study Group. Stringhini S, et al. Among authors: baysson h. Lancet Infect Dis. 2021 May;21(5):600-601. doi: 10.1016/S1473-3099(21)00054-2. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539733 Free PMC article. No abstract available.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Stringhini S, et al. Among authors: baysson h. Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11. Lancet. 2020. PMID: 32534626 Free PMC article.
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. Leidi A, et al. Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495. Clin Infect Dis. 2022. PMID: 34043763 Free PMC article.
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS; SEROCoV-WORK + Study Group; Guessous I. Stringhini S, et al. Among authors: baysson h. Nat Commun. 2021 Jun 8;12(1):3455. doi: 10.1038/s41467-021-23796-4. Nat Commun. 2021. PMID: 34103517 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study.
Richard A, Wisniak A, Perez-Saez J, Garrison-Desany H, Petrovic D, Piumatti G, Baysson H, Picazio A, Pennacchio F, De Ridder D, Chappuis F, Vuilleumier N, Low N, Hurst S, Eckerle I, Flahault A, Kaiser L, Azman AS, Guessous I, Stringhini S. Richard A, et al. Among authors: baysson h. Scand J Public Health. 2022 Feb;50(1):124-135. doi: 10.1177/14034948211048050. Epub 2021 Oct 19. Scand J Public Health. 2022. PMID: 34664529 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I; Specchio-COVID19 study group. Stringhini S, et al. Among authors: baysson h. Euro Surveill. 2021 Oct;26(43):2100830. doi: 10.2807/1560-7917.ES.2021.26.43.2100830. Euro Surveill. 2021. PMID: 34713799 Free PMC article.
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study.
Leidi A, Berner A, Dumont R, Dubos R, Koegler F, Piumatti G, Vuilleumier N, Kaiser L, Balavoine JF, Trono D, Pittet D, Chappuis F, Kherad O, Courvoisier DS, Azman AS, Zaballa ME, Guessous I, Stringhini S; SEROCoV-WORK+ study group. Leidi A, et al. Occup Environ Med. 2022 Feb;79(2):116-119. doi: 10.1136/oemed-2021-107924. Epub 2021 Dec 8. Occup Environ Med. 2022. PMID: 34880045
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study.
Wisniak A, Menon LK, Dumont R, Pullen N, Regard S, Dubos R, Zaballa ME, Baysson H, Courvoisier D, Kaiser L, Pittet D, Azman AS, Stringhini S, Guessous I, Balavoine JF, Kherad O, The SEROCoV-Work Study Group. Wisniak A, et al. Among authors: baysson h. Viruses. 2021 Dec 28;14(1):43. doi: 10.3390/v14010043. Viruses. 2021. PMID: 35062247 Free PMC article.
63 results